Cantitate/Preț
Produs

Blood cells in nuclear medicine, part I: Cell kinetics and bio-distribution: Developments in Nuclear Medicine, cartea 6

Editat de M.R. Hardeman, Y. Najean
en Limba Engleză Paperback – 8 oct 2011

Din seria Developments in Nuclear Medicine

Preț: 37643 lei

Preț vechi: 39624 lei
-5% Nou

Puncte Express: 565

Preț estimativ în valută:
7203 7520$ 5961£

Carte tipărită la comandă

Livrare economică 04-18 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789400960299
ISBN-10: 9400960298
Pagini: 436
Ilustrații: 431 p.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.61 kg
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

1 Approaches to radiolabelling blood d-c cells: past, present and future.- Cell, Labelling Techniques.- 2 Labelling techniques of granulocytes and platelets with 111In-oxinate.- 3 111Indium-labelling of human washed platelets; kinetics and in vivo sequestration sites.- 4 111Indium loss from platelets by in vitro and ex vivo manipulation.- Platelets: Kinetic Studies.- 5 The maturation of megakaryocytes and their precursors.- 6 Megakaryocytic precursors.- 7 Methods of quantification of platelet production in man. A critical analysis.- 8 Platelet production rate determination with (75Se)-seleno-methionine.- 9 Platelet kinetics: the state of the art.- 10 Platelet kinetics.- 11 Evaluation of models to determine platelet life span and survival curve shape.- 12 Comparison of three methods evaluating platelet survival time in patients with prosthetic heart valve.- 13 In vivo kinetics of simultaneously injected 111In- and 51Cr-labelled human platelets: on the significance of the platelet isolation yield from blood prior to labelling.- 14 Simultaneous kinetics and external countings of autologous 111In-oxine labelled platelets and homologous 51Cr labelled platelets.- 15 Platelet survival time (51Cr) and platelet production time (Aspirin-MDA method): a simultaneous evaluation in patients affected with cancers.- Labelled Platelets: Scintigraphic Studies.- 16 Survival time and organ distribution of 111In-oxine-labelled human platelets in normal subjects.- 17 111In-labelled platelets in the diagnosis of kidney transplant rejection.- 18 Continuous monitoring of human kidney transplants by autologous labelled platelets.- 19 Use of 111In-labelled platelets in cardiovascular disease.- 20 Homocystinuria: kinetics and distribution of 111In-labelled platelets.- 21 Noninvasive radioisotopictechniques for detection of platelet deposition in mechanical and bovine pericardial mitral valve prostheses and in vitro quantitation of visceral microembolism.- Platelets, Beta-Thromboglobulin, Platelet Factor 4.- 22 Beta-thromboglobulin, present state of the art.- 23 Beta-thromboglobulin and platelet factor 4 in polycythemia and thranbocythemia.- 24 Beta-thromboglobulin, platelet factor 4 and coronary heart disease.- 25 Beta-thromboglobulin release and thranboxane synthesis in diabetic platelets: effect of glycemic control and retinopathy.- 26 Hemorheology and platelet activation: theoretical and experimental aspects.- Granulocytes.- 27 111In-leukocyte scintigraphy in the diagnosis of vascular graft infection.- 28 Diagnosis of intra abdominal inflammatory processes with 111In-labelled leucocytes.- 29 111In-autologous leucocytes in the diagnosis and management of inflammatory bowel disease.- 30 Diagnosis of orthopedic prostheses infection with 111In-labelled leucocytes.- 31 Radiation dosimetry of 111In-oxinate labeled leucocytes.- Lymphocytes.- 32 The lymphocyte in Hodgkin’s disease: has it lost its way?.- 33 Labelling of human lymphocytes with 111In-oxinate.- Erythrocytes.- 34 Tc99m labelling of red blood-cells and their clinical application.